Last week brought
news that Teva and consumer goods giant P&G will be partnering, combining their over-the-counter pharma businesses outside of North America. In February,
Fuji and Samsung made moves in biopharm and biogenerics. P&G has core pharma businesses but is still primarily known as a consumer goods company, fitting the prediction that &quo